Sagient Research Products About Us Contact Us
Search BioMedTracker  
  Drugs Covered: 6,079
  Catalysts Covered: 6,100
  Revenue Models: 449
  Companies Covered: 1,506
  Companies Evaluated:  26
Search
Catalysts Drug Profiles
Impact Events Company Profiles
Target    Indication   
Trials    All   
Thought Leader Opinion   

Sample Reports
05/16/12 2012 Pre-ASCO Report
05/11/12 2012 Post-EASL Report
05/01/12 2012 ASCO Planner
04/10/12 2012 Pre-EASL Report
04/05/12 2012 EASL Planner
04/03/12 Q2 2012 BMT Outlook Report
03/02/12 Biosimilar Draft Guidance Summary
01/31/12 Early 2012 BMT Outlook Report
01/13/12 JP Morgan Conference Review
01/09/12 2011 Post-ASH Report
12/08/11 2011 Post-AASLD/HCV Update Report
12/07/11 2011 Post-CTAD Report
12/06/11 2011 Pre-ASH Report
12/02/11 2011 ASH Planner   More...
About Us
BioMedTracker provides evidence-based and event-driven biotech and pharmaceutical research to the institutional community. Formed in 2002 through a joint-venture between PCS Research Technology, Inc. and BioMedech Investor, Inc., BioMedTracker combines PCS Research Technology's interactive data and research distribution capabilities with BioMedech's unparalleled insight and uncompromising clarity into the biotech industry, emerging technologies, and the drug development pipeline.
 
 
  Contact Us
  The BioMed Authors
  BioMedTracker in the News
 Questions? Email Customer Support Privacy Policy     Important Legal Disclosure 

Copyright © 2012 Sagient Research Systems, Inc.  All rights reserved. Web1